Cytokinetics | CYTK - Cost Of Sales

Stock Price
62.44
Daily Change
-0.19 -0.30%
Monthly
-4.14%
Yearly
35.74%
Q1 Forecast
65.83

Cytokinetics reported $99.23M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 26.22M 4.58M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cytokinetics USD 99.23M 13.32M Sep/2025
Eisai JPY 51.08B 5.56B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Exelixis USD 26.48M 7.91M Dec/2025
Geron USD 1.31M 263K Dec/2025
Halozyme Therapeutics USD 102.15M 29.14M Dec/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
Ligand Pharmaceuticals USD 11.9M 733K Sep/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025